PDB29 PHARMACOECONOMIC EVALUATION OF CABERGOLINE FOR THE MANAGEMENT OF HYPERPROLACTINEMIA CAUSED BY HYPOPHYSEAL MICROADENOMA IN MEXICO
Abstract
Authors
M Guillen-Gonzlez F Diez-Canseco L Zapata GY Vega-Hernandez R Rivas H Ramirez J Mould-Ouevedo G Davila-Loaiza